Table 2.
Group | Lower risk MDS | CCUS | AA | Control |
---|---|---|---|---|
n = 45 | n = 21 | n = 24 | n = 38 | |
Age (Year) | 63(26–84) | 45(14–82) | 41.5(11–69) | 54(17–80) |
Male: Female | 25:20 | 8:13 | 13:11 | 13:25 |
HGB (g/L) | 101(38–149) | 81(39–118) | 71(28–117) | 78(49–109) |
PLT × 10^9/L | 112(3–591) | 39(6–186) | 29(3–98) | 324(84–642) |
ANC × 10^9/L | 1.84 | 1.61 | 1.13 | 3.29 |
(0.29–8.97) | (0.25–4.28) | (0.27–2.41) | (1.38–9.60) |
MDS myelodysplastic syndrome, CCUS clonal cytopenias of undetermined significance, AA aplastic anemia, HGB hemoglobin, PLT platelet, ANC absolute neutrophil count